Flomax, Tamsulosin News

Generic drug maker Impax Laboratories Inc. has been sued over its copy of a drug to treat prostate enlargement.

If you watch television, you've seen ads for Flomax, and you probably know more about benign prostatic hyperplasia than you bargained for.

No need to go searching all over for the latest information on new drugs, indications, medication errors and more.

If you're about to prescribe an alpha blocker for an older adult with hypertension or a prostate or urinary retention problem, consider whether the patient has cataracts before you prescribe.

Enlarged prostate: An article in Monday's Health section about treatments for prostate enlargement gave inaccurate descriptions of two drugs used to treat the condition. via Los Angeles Times

This press release is intended for business journalists and analysts/investors. Please note that this release may not have been issued in every market in which GSK operates. via WebWire

Patients with moderate to severe urinary symptoms may be treated by medications, like tamsulosin , alfusozin , doxazosin , or terazosin , which relax smooth muscle within the prostate gland and allow urine to ... via Associated Content

Garnering more patient share than any other alpha blocker in first- and second-line therapy for benign prostatic hyperplasia, Flomax holds a 55.2 percent first-line patient share, compared with 12.4 percent for ... via Rehab Management

“However, I'm the first to concede that the marketing and advertising of those drugs has been extraordinarily effective.”

An expected surge in sales for medical devices that help men urinate hasn't happened - at least not yet - for three Twin Cities companies. via Twincities.com

Initial question: My patient is listed for cataract surgery. He takes tamulosin for bph and has been told that this can put him at risk of floppy iris syndrome during surgery. via NLH Question Answering Service

“We, therefore, leave the choice as to whether generic drugs will be prescribed or used to the physician and the patient after relevant discussion has been made with the patient.”

T he Medical Association of Jamaica has welcomed a list of new drugs that has been added to the National Health Fund programme. via Jamaica Gleaner

“Urologists are generally not willing to accept trade-offs in efficacy, safety and tolerability or delivery when considering a benign prostatic hyperplasia drug with a lower incidence of sexual side effects than Flomax”

Tamsulosin/dutasteride has competitive advantages in efficacy, safety, tolerability and delivery. via Rehab Management

Main Category: Urology / Nephrology Also Included In: Regulatory Affairs / Drug Approvals ; Pharma Industry / Biotech Industry ; Prostate / Prostate Cancer Article Date: 04 Feb 2008 - 11:00 PST newsletters Teva ... via Medical News Today

Teva Pharmaceutical Industries Ltd. Thursday said it received tentative approval from the Food and Drug Administration for its abbreviated new drug application for its tamsulosin hydrochloride capsules. via Quamnet

“People whose marriages break up run a higher risk of depression than those who remain with their spouses, a new Statistics Canada study shows.”

A study of 900 women found that those who exercised would lose weight. Another study found super models make us feel fat, while another said exercise uses more calories than just lying around. via National Post

Last Updated:December 10. 2007 5:10PM Published: December 11. 2007 3:30AM Q: If I am taking a beta blocker for heart disease, can I take an alpha-adrenergic blocker such as Flomax for prostate problems? Will ... via Times Daily

TORONTO, Nov. 20 /CNW/ -- Ranbaxy Pharmaceuticals Canada Inc. , a wholly owned subsidiary of Ranbaxy Laboratories Limited , announced today that RLL had received approval in Canada to manufacture and market ... via Canada NewsWire

Traveling out of the country on a business trip or holiday? Before you leave Indian shores, buy all the medicines you may require during your trip and make sure you have them in adequate quantity. via Hindustan Times

“Growth was seen as remaining sluggish during the first part of next year, then strengthening as the effects of tighter credit and the housing correction begin to wane”

NEW DELHI: Ranbaxy Laboratories has resolved a patent dispute with Astellas Boehringer Ingelheim over Flomax used in treatment of benign enlargement of prostate. via The Times of India

Ranbaxy Pharmaceuticals Inc. will bring a generic version of the prostate drug Flomax to market in March 2010. via Jacksonville Business Journal